Background The role of liver transplantation in patients positive for the hepatitis B surface
antigen (HBsAg) is controversial because of the high rate of recurrent hepatitis B virus (HBV) …

Occult hepatitis B virus (HBV) infection is one of the most challenging topics in the field of
viral hepatitis with its virological and clinical relevance being debated for more than 30 years. …

The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on
acute-on-chronic liver failure (ACLF) in 2004, with a mandate to develop consensus …

Background A 6-month abstinence from alcohol is usually required before patients with severe
alcoholic hepatitis are considered for liver transplantation. Patients whose hepatitis is not …

Background & Aims Acute-on-chronic liver failure (ACLF) is a frequent syndrome (30%
prevalence), characterized by acute decompensation of cirrhosis, organ failure(s) and high short-…

Background Sorafenib is the recommended treatment for patients with advanced hepatocellular
carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective …

BACKGROUND & AIMS:: Type 1 hepatorenal syndrome (HRS) is a severe complication of
cirrhosis associated with a short median survival time (<2 weeks). Although the administration …

The first consensus report of the working party of the Asian Pacific Association for the Study
of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in …

Acute‐on‐chronic liver failure (ACLF) in cirrhosis is characterized by acute decompensation
(AD), organ failure(s), and high short‐term mortality. Recently, we have proposed (systemic …

Background & Aims In phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin
with boceprevir or telaprevir) seems to be similar in HCV treatment-experienced …